Skip to main content
. 2008 Jun 6;295(2):H491–H498. doi: 10.1152/ajpheart.00464.2008

Fig. 3.

Fig. 3.

A: treatment with soluble RAGE (sRAGE) to neutralize RAGE signaling partially restored ACh-induced vasodilation in diabetic mice (n = 6) but did not affect the vasodilation in control mice (n = 5). B: NAD(P)H oxidase activity was higher in diabetic mice, but sRAGE or nuclear factor-κB (NF-κB) inhibitor MG132 decreased NAD(P)H oxidase activity in diabetic vs. control mice (n = 6). *P < 0.05 vs. control, #P < 0.05 vs. diabetic.